# MYTESI
> **NDA202292** · New Drug Application · Sponsor: NAPO PHARMS INC · Approved 2012-12-31
## Drug
- **FDA Application Number:** NDA202292
- **Application type:** New Drug Application
- **Brand name:** MYTESI
- **Generic name:** CROFELEMER
- **Active ingredients:** CROFELEMER
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NAPO PHARMS INC
- **Manufacturer:** Napo Pharmaceuticals, Inc.
- **First approval:** 2012-12-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202292)
---
*AI Analytics · CC0 1.0*